Toward a Total Cure for Acute Lymphoblastic Leukemia

Abstract

REFERENCES 1. Vardy J, Wefel JS, Ahles T, et al: Cancer and cancer-therapy related cognitive dysfunction: An international perspective from the Venice cognitive workshop. Ann Oncol 19:623-629, 2008 2. McEwen B: Estrogen actions throughout the brain. Recent Prog in Horm Res 7:357-384, 2002 3. Eberling JL, Wu C, Tong-Turnbeaugh R, et al: Estrogen and tamoxifenassociated effects on brain structure and function. Neuroimage 21:364-371, 2004 4. Legault C, Maki PM, Resnick SM, et al: Effects of tamoxifen and raloxifene on memory and other cognitive abilities: Cognition in the study of tamoxifen and raloxifene. J Clin Oncol 27:5144-5152, 2009 5. Vogel VG, Costantino JP, Wickerham DL, et al: Effects of tamoxifen vs raloxifene on the risk of developing invasive breast cancer and other disease outcomes: The NSABP Study of Tamoxifen and Raloxifene (STAR) P-2 trial. JAMA 295:2727-2741, 2006 6. Castellon SA, Ganz PA, Bower JE, et al: Neurocognitive performance in breast cancer survivors exposed to adjuvant chemotherapy and tamoxifen. J Clin Exp Neuropsychol 26:955-969, 2004 7. Silverman DH, Dy CJ, Castellon SA, et al: Altered frontocorical, cerebellar, and basal ganglia activity in adjuvant therapy-treated survivors, 5-10 years after chemotherapy. Breast Cancer Res Treat 103:303-311, 2007 8. Paganini-Hill A, Clark LJ: Preliminary assessment of cognitive function in breast cancer patients treated with tamoxifen. Breast Cancer Res Treat 64:165176, 2000 9. Bender CM, Sereika SM, Berga SL, et al: Cognitive impairment associated with adjuvant therapy in breast cancer. Psychooncol 15:422-430, 2006 10. Shilling V, Jenkins V, Fallowfield L, et al: Does hormone therapy for the treatment of breast cancer have a detrimental effect on memory and cognition? A pilot study. Psychooncology 13:61-66, 2004 11. Palmer JL, Trotter T, Joy AA, et al: Cognitive effects of tamoxifen in pre-menopausal women with breast cancer compared to healthy controls. J Cancer Surviv 2:275-278, 2008 12. Greendale GA, Huang MH, Wight RG, et al: Effects of menopause transition and hormone use on cognitive performance in midlife women. Neurology 72:1850-1857, 2009 13. Land SR, Wickerham DL, Costantino JP, et al: Patient-reported symptoms and quality of life during treatment with tamoxifen or raloxifene for breast cancer prevention: The NSABP Study of Tamoxifen and Raloxifene (STAR) P-2 trial. JAMA 295:2742-2751, 2006